Skip to main content
Applied Therapeutics, Inc. logo

Applied Therapeutics, Inc. — Investor Relations & Filings

Ticker · APLT ISIN · US03828A1016 LEI · 549300KL3IJPHZM2GR04 US Manufacturing
Filings indexed 491 across all filing types
Latest filing 2026-02-17 Major Shareholding Noti…
Country US United States of America
Listing US APLT

About Applied Therapeutics, Inc.

https://www.appliedtherapeutics.com/

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel drug candidates for rare diseases with high unmet medical needs. The company's pipeline is centered on creating transformative treatments by targeting validated molecular pathways. Its primary focus is on the development of aldose reductase inhibitors (ARIs) for a range of conditions. Key therapeutic areas include rare metabolic and central nervous system (CNS) diseases, such as Classic Galactosemia, Sorbitol Dehydrogenase (SORD) deficiency, and PMM2-CDG, as well as Diabetic Cardiomyopathy. The company's approach aims to accelerate the drug development timeline by utilizing biomarkers and established clinical endpoints.

Recent filings

Filing Released Lang Actions
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-17 English
4 Filing
Director's Dealing
2026-02-04 English
4 Filing
Director's Dealing
2026-02-03 English
S-8 POS Filing
Regulatory Filings
2026-02-03 English
4 Filing
Director's Dealing
2026-02-03 English
8-K Filing
Regulatory Filings
2026-02-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.